Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023.

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023

Option Care Health's (OPCH) Q3 results are likely to be driven by sustained strong utilization.

What's in Store for Option Care Health (OPCH) in Q3 Earnings?

Chemed

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?

OPCH or CHE: Which Is the Better Value Stock Right Now?

Option Care Health has had a stellar run in '23, backed by robust fundamentals and growth rates. Recent pullback has opened the gates for additional allocations for long-term positioning. The market may be under-reflecting critical factors in OPCH's business returns at its current appraisal of the company.

Option Care Health: Market May Be Under-Reflecting Critical Factors, Reiterate Buy

Axcelis Technologies

Compass Minerals

Lantheus Holdings

Super Micro Computer

Simpson Manufacturing

Weatherford International PLC

Right now, investors would be wise to consider the small-cap stocks that populate the Russell 2000 Index. The Russell 2000 Index represents the smallest firms by market capitalization.

7 Small-Cap Stocks to Buy Before the Next Recession Hits

Apollo Global Management

Identifying stocks with high earnings growth is a powerful strategy for investors looking to secure high returns. Earnings growth is a leading indicator of a company's financial health and its potential for future stock price appreciation.

2 Top Ranked Stocks with Sky High Earnings Growth Forecasts

Akero Therapeutics Inc

CymaBay Therapeutics

MoonLake Immunotherapeutics

Olema Pharmaceuticals

Rapt Therapeutics Inc

Sensus Healthcare

While the health innovation space presents wild risks, you could potentially swing the odds in your favor with strong buy biotech stocks. Specifically, these ideas represent publicly traded biotechnology firms that enjoy the highest possible consensus rating among Wall Street analysts.

7 ‘Strong Buy' Biotech Stocks to Rejuvenate Your Portfolio

BANNOCKBURN, Ill., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2023 on Wednesday, October 25, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Third Quarter 2023 Financial Results and Host Conference Call

Option Care (OPCH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Recent Price Trend in Option Care (OPCH) is Your Friend, Here's Why

Shift4 Payments

GEE Group

FOUR, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15, 2023.

Best Growth Stocks to Buy for September 15th

American Woodmark

MPTI, AMWD and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 8, 2023.

Best Growth Stocks to Buy for September 8th

DaVita

Encompass Health

RadNet

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.

4 Stocks to Buy in a Booming Outpatient Home Health Industry

Consolidated Water

Marriott

MAR, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 1, 2023.

Best Growth Stocks to Buy for September 1st

BANNOCKBURN, Ill., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, being held in New York, on Tuesday, September 12, 2023, including a fireside chat at 2:55pm ET.

Option Care Health to Participate in Upcoming Investor Conference

OPCH vs. CHE: Which Stock Is the Better Value Option?

Franklin Covey

Sterling Construction

OPCH, STRL and FC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 25, 2023.

Best Growth Stocks to Buy for August 25th

Option Care (OPCH) Is a Great Choice for 'Trend' Investors, Here's Why

Panasonic Holdings Corp

FOUR, PCRFY and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2023.

Best Growth Stocks to Buy for August 18th

Grocery Outlet

Nidec Corp

GO, OPCH and NJDCY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 17, 2023.

Best Growth Stocks to Buy for August 17th

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?

OPCH vs. CHE: Which Stock Should Value Investors Buy Now?

KE Holdings

OPCH, PCRFY and BEKE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 11, 2023.

Best Growth Stocks to Buy for August 11th

Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why Option Care (OPCH) Might be Well Poised for a Surge

Toll Brothers

TOL, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2023.

Best Growth Stocks to Buy for August 4th

Mr. Cooper Group Inc

Masco

PulteGroup

Solaris Oilfield Infrastructure

COOP, MAS, OPCH, SOI and PHM are five stocks with explosive relative price strength.

Time to Add These 5 Relative Price Strength Stocks

Option Care Health, Inc. (NASDAQ:OPCH ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Mike Shapiro – Chief Financial Officer John Rademacher – Chief Executive Officer Conference Call Participants Lisa Gill – JPMorgan Brian Tanquilut – Jefferies Matt Larew – William Blair David MacDonald – Truist Pito Chickering – Deutsche Bank Jamie Perse – Goldman Sachs Michael Petusky – Barrington Research Operator Good day and thank you for standing by. Welcome to the Option Care Health Second Quarter 2023 Earnings Conference Call.

Option Care Health, Inc. (OPCH) Q2 2023 Earnings Call Transcript

News for Option Care Health Stock (OPCH)